Comparative analysis of various in vitro COT kinase assay formats and their applications in inhibitor identification and characterization

Roux, 2004, ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions, Microbiol. Mol. Biol. Rev., 68, 320, 10.1128/MMBR.68.2.320-344.2004 Schaeffer, 1999, Mitogen-activated protein kinases: specific messages from ubiquitous messengers, Mol. Cell. Biol., 19, 2435, 10.1128/MCB.19.4.2435 Kyriakis, 2001, Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation, Physiol. Rev., 81, 807, 10.1152/physrev.2001.81.2.807 Hill, 1995, Transcriptional regulation by extracellular signals: mechanisms and specificity, Cell, 80, 199, 10.1016/0092-8674(95)90403-4 Hommes, 2003, Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti–inflammatory targets, Gut, 53, 144, 10.1136/gut.52.1.144 Cohen, 2002, Protein kinases: the major drug targets of the twenty-first century?, Nat. Rev. Drug Discov., 1, 309, 10.1038/nrd773 Salmeron, 1996, Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase, EMBO J., 15, 817, 10.1002/j.1460-2075.1996.tb00417.x Dumitru, 2000, TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway, Cell, 103, 1071, 10.1016/S0092-8674(00)00210-5 Eliopoulos, 2003, Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40, EMBO J., 22, 3855, 10.1093/emboj/cdg386 Aoki, 1991, Identification and characterization of protein products of the cot oncogene with serine kinase activity, Oncogene, 6, 1515 Aoki, 1993, The human cot proto-oncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation, J. Biol. Chem., 268, 22723, 10.1016/S0021-9258(18)41587-6 Miyoshi, 1991, Structure and transforming potential of the human cot oncogene encoding a putative protein kinase, Mol. Cell. Biol., 11, 4088, 10.1128/MCB.11.8.4088 Belich, 1999, TPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB1 p105, Nature, 397, 363, 10.1038/16946 Lang, 2004, ABIN-2 forms a ternary complex with TPL-2 and NF-κB1 p105 and is essential for TPL-2 protein stability, Mol. Cell. Biol., 24, 5235, 10.1128/MCB.24.12.5235-5248.2004 Jia, 2005, Purification and kinetic characterization of recombinant human mitogen-activated protein kinase kinase kinase COT and the complexes with its cellular partner NF-κB1 p105, Arch. Biochem. Biophys., 441, 64, 10.1016/j.abb.2005.06.020 M. Mabile, G. Mathis, E.J.P. Jolu, D. Pouyat, C. Dumont, Method of measuring luminescence in an assay by luminescence, patent WO 92:13264 (1991). Mathis, 1993, Rare earth cryptates and homogeneous fluoroimmunoassays with human sera, Clin. Chem., 39, 1953, 10.1093/clinchem/39.9.1953 Han, 2005, Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors, Bioorg. Med. Chem. Lett., 15, 5467, 10.1016/j.bmcl.2005.08.097 Ferrell, 1996, Tripping the switch fantastic: how a protein kinase cascade can convert graded inputs into switch-like outputs, Trends Biochem. Sci., 21, 460, 10.1016/S0968-0004(96)20026-X Antonsson, 1999, An in vitro 96-well plate assay of the mitogen-activated protein kinase cascade, Anal. Biochem., 267, 294, 10.1006/abio.1998.2986 Dudley, 1995, A synthetic inhibitor of the mitogen-activated protein kinase cascade, Proc. Natl. Acad. Sci. USA, 92, 7686, 10.1073/pnas.92.17.7686 Alessi, 1995, PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo, J. Biol. Chem., 270, 27489, 10.1074/jbc.270.46.27489 Favata, 1998, Identification of a novel inhibitor of mitogen-activated protein kinase kinase, J. Biol. Chem., 273, 18623, 10.1074/jbc.273.29.18623 Ballif, 2001, Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)–MAPK cell survival signals, Cell Growth Differ., 12, 397 Nakagami, 2004, OMTK1, a novel MAPKKK, channels oxidative stress signaling through direct MAPK interaction, J. Biol. Chem., 279, 26959, 10.1074/jbc.M312662200 Whitmarsh, 1998, A mammalian scaffold complex that selectively mediates MAP kinase activation, Science, 281, 1671, 10.1126/science.281.5383.1671 Ninomiya-Tsuji, 1999, The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascades in the IL-1 signalling pathway, Nature, 398, 252, 10.1038/18465 Chen, 2001, MAP kinases, Chem. Rev., 101, 2449, 10.1021/cr000241p Pearson, 2001, Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions, Endocrinol. Rev., 22, 153 Dan, 2001, The Ste20 group kinases as regulators of MAP kinase cascades, Trends Cell Biol., 11, 220, 10.1016/S0962-8924(01)01980-8 Huse, 2002, The conformational plasticity of protein kinases, Cell, 109, 275, 10.1016/S0092-8674(02)00741-9